UnitedHealth Group’s third-quarter 2026 results are scheduled for before the market opens on Tuesday, October 13, with a call at 8:00 a.m. ET. As of October 3, the results are not yet available. The number to watch when they arrive is the medical care ratio (MCR): medical costs divided by premium revenue.
What the medical care ratio tells investors
MCR measures how much of UnitedHealth’s premium revenue goes to medical costs. A lower ratio can mean medical costs are taking a smaller share of premium revenue, but it is not a complete measure of profitability or a stand-alone verdict on the quarter. Business mix and the reasons the ratio moved matter.
UnitedHealth’s July 16, 2026 full-year outlook was an MCR of 88.1%, plus or minus 25 basis points. Compare the Q3 figure with that full-year outlook, rather than treating it as a forecast for Q3 alone. The company reported the outlook alongside Q2 results in its second-quarter 2026 release.
How to interpret the Q3 figure
Read the reported ratio together with management’s explanation of what changed. UnitedHealth’s SEC-filed materials identify several influences on MCR:
#1 Best Overall
- Prior-period reserve development: adjustments related to estimates for earlier periods can affect the ratio reported now.
- Affordability and medical-cost-management initiatives: company efforts in these areas can influence medical spending and the reported ratio.
- Pricing trends: premium pricing affects the revenue side of the calculation.
- Medical-cost trends: the filing says costs remained above historical levels, a context relevant to the ratio.
Because these factors can push the ratio in different directions, a change from the full-year outlook deserves an explanation, not an automatic positive or negative label. UnitedHealth also says segment measures can help investors assess business mix and pricing trends; use those results to understand what the consolidated MCR may obscure.
Put the ratio in the context of Q2
UnitedHealth reported $112.0 billion in Q2 2026 revenue and adjusted earnings per share of $6.38. In that release, it raised its full-year adjusted EPS outlook to $19.50–$20.00 per share and gave the 88.1% ± 25 basis-point MCR outlook. Those figures provide the latest reported context, not Q3 results.
Rank #2
- Ideal for Gifting
- Ideal for a bookworm
- Compact for travelling
The company’s Q2 release quoted CEO Stephen Hemsley saying the results and outlook reflected continuing work to simplify operations, improve affordability and the healthcare experience for patients and care providers, and use modern technology to improve outcomes. The Q3 report and call will show how management describes progress and the forces behind the numbers.
Independent reader supportYour contribution helps us test, update, and keep practical guides available for everyone.When to get the report
UnitedHealth announced the schedule on September 15: the Q3 release is set for before market open on October 13, 2026, followed by an 8:00 a.m. ET investor call. The company’s investor page is the place to check for the published results and call materials.
Quick Recap
Best Value
- It can be a gift option
- Comes with secure packaging
- Helpful in various ways
Rank #4
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
